Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Prevention of Post-operative Urinary Retention in Men After Rectum Resection
NCT05941806Phase 3Recruiting
- Sponsor
- CHU de Québec-Université Laval
- Start
- Nov 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamsulosin in urinary retention, sponsored by CHU de Québec-Université Laval. Started Nov 2023; status: recruiting.
02
Drugs
tamsulosin
03
Conditions
urinary retention
Beyond the preview
Go deeper on NCT05941806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05941806.